Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04495725Not ApplicableCompleted

Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain

Role: lead

NCT05554146Not ApplicableCompleted

Pain Inflammation and Cannabis in HIV

Role: collaborator

NCT04308148Completed

Does Medical Cannabis Reduce Opioid Use in Adults With Pain

Role: collaborator

NCT04860089Withdrawn

Pain, Inflammation, and Cannabis in HIV

Role: collaborator

NCT05042765Completed

Entheogen Resurgence

Role: lead

All 5 trials loaded